Buy InflaRx Stock | IFRX Stock Price & Latest News | Public
IFRX

InflaRx

$0.00 (0.00%)Today
    Small Market Cap

    About IFRX

    InflaRx NV is a clinical-stage biopharmaceutical company, which engages in the discovery and development of inhibitors of the complement activation factor known as C5a. Its products include IFX-1 and IFX-2. The company was founded by Niels Christoph Riedemann, Renfeng G...Read more

    Buy any stock with any amount of money.

    Download the App
    Download the app

    What Wall Street Thinks

    Events

    List of events that could affect this stock.

    Earnings

    The value each share was expected to gain vs. the value that each share actually gained

    0
    -0.19
    -0.39
    -0.58
    Q4 2019
    Q1 2020
    Q2 2020
    Q3 2020

    Expected EPS
    Q3 2020

    -$0.36

    Actual EPS
    Q3 2020

    Stats

    Market Cap$116,68M
    Volume9,03k
    Price-to-Earnings Ratio
    Dividend Rate
    Dividend Yield
    1 Year High$9.70
    1 Year Low$2.17
    Open$4.50
    High$4.51
    Low$4.31

    Buy any stock with any amount of money.

    Download the App
    Download the app